ACETAMINOPHEN AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Acetaminophen And Codeine Phosphate patents expire, and when can generic versions of Acetaminophen And Codeine Phosphate launch?
Acetaminophen And Codeine Phosphate is a drug marketed by Teva, Actavis Mid Atlantic, Chartwell, Chartwell Molecular, Dava Pharms Inc, Genus Lifesciences, Pai Holdings, Pharmobedient, Strides Pharma, Able, Am Therap, Amneal Pharms Ny, Ani Pharms, Aurolife Pharma Llc, Duramed Pharms Barr, Elite Labs Inc, Everylife, Fosun Pharma, Halsey, Hibrow Hlthcare, Kv Pharm, Lederle, Mikart, Mutual Pharm, Puracap Pharm, Purepac Pharm, Rhodes Pharms, Roxane, Sandoz, Specgx Llc, Strides Pharma Intl, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Valeant Pharm Intl, Vitarine, Warner Chilcott, Watson Labs, Watson Labs Florida, and Whiteworth Town Plsn. and is included in eighty-nine NDAs.
The generic ingredient in ACETAMINOPHEN AND CODEINE PHOSPHATE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Codeine Phosphate
A generic version of ACETAMINOPHEN AND CODEINE PHOSPHATE was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN AND CODEINE PHOSPHATE?
- What are the global sales for ACETAMINOPHEN AND CODEINE PHOSPHATE?
- What is Average Wholesale Price for ACETAMINOPHEN AND CODEINE PHOSPHATE?
Summary for ACETAMINOPHEN AND CODEINE PHOSPHATE
| US Patents: | 0 |
| Applicants: | 40 |
| NDAs: | 89 |
| Finished Product Suppliers / Packagers: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 69 |
| DailyMed Link: | ACETAMINOPHEN AND CODEINE PHOSPHATE at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN AND CODEINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roxane Laboratories | Phase 1 |
Pharmacology for ACETAMINOPHEN AND CODEINE PHOSPHATE
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |

